Clarivate (CLVT) Q2 FY26 earnings call

Clarivate delivered on its value creation plan in Q2 FY26, improving organic ACV growth and expanding profit margins, while advancing AI innovation with new product launches like Web of Science Research Intelligence and IP-One. The company announced the divestiture of its Life Sciences and Health segment to sharpen focus on AI-driven intelligence, simplify its operating model, and strengthen its balance sheet through debt reduction, positioning for accelerated organic growth in the second half of 2026 and into 2027.